On September 5, 2018, at 1:30 PM, Lachman Consultant Services’ CEO and President and CEO will be moderating a panel on Data Integrity at the AAM GRx + Biosims meeting. Ms. Zipp will be joined by Derek Glover (Head of Global Quality Systems and Compliance, Mylan Pharmaceuticals Inc.), Sarah Barkow, Ph.D. (Lead Consumer Safety Officer, Office of Manufacturing Quality, Office of Compliance, FDA), Carmelo Rosa, BS, MS, PsyD (Director, Division of Drug Quality I, Office of Compliance, FDA) and Howard Sklamberg, JD (Partner, Akin Gump Strauss Hauer & Feld LLP), This presentation will discussion data integrity across the life cycle of product management from development to commercialization and post market surveillance. The discussion will also highlight the controls and cultural aspects as well as current trends. Please join us in what promises to be an interesting discussion with perspectives from both industry and regulators on the relevant topic.